Dr. Deaver brings extensive expertise and experience to Brain Trust Bio in medicinal chemistry, non-clinical pharmacology, toxicology and the drug discovery, development, and approval processes. Dr. Deaver spent 17 years at Alkermes, Inc., where he directed life sciences and toxicology before becoming vice president of non-clinical research and development. Prior to that, he spent several years as a professor and graduate program chair at Penn State University. Dr. Deaver spent many years developing strategies for toxicology programs to support all states of clinical development, from Phase 1 through NDA submission. He has provided scientific leadership in designing and executing toxicology programs to support a variety of drug candidates including inhaled proteins, inhaled small molecules, injectable extended release drug products, orally delivered small molecules and a biologic for oncology. He has established expertise in both cell-based and mouse models, with a focus on GPCR ligands and receptors. He has been awarded numerous U.S. patents, and has been published extensively in various professional and academic journals, and book chapters. Dr. Deaver received bachelor’s and master’s degrees from the University of Maryland College Park, and his PhD from West Virginia University, Morgantown.
